No Heart Benefit Seen With Fibrates In Diabetics, National Institutes of Health (NIH) Study

ATLANTA (Reuters) - Adding a triglyceride-lowering drug to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study.